Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,143,500 | 5,492,900 | 5,084,800 | 4,939,600 | 4,972,200 |
| Marketable Securities | 1,708,900 | 1,753,800 | 1,523,300 | 1,347,400 | 1,410,600 |
| Receivables | 2,134,300 | 1,996,100 | 2,052,800 | 1,946,400 | 1,893,500 |
| Inventories | 1,765,100 | 1,766,700 | 1,686,800 | 1,626,800 | 1,499,300 |
| TOTAL | $12,543,700 | $11,730,300 | $11,201,000 | $10,569,600 | $10,427,900 |
| Non-Current Assets | |||||
| PPE Net | 1,665,000 | 1,608,400 | 1,520,300 | 1,425,100 | 1,335,100 |
| Investments And Advances | 5,789,100 | 5,749,900 | 5,712,300 | 5,722,800 | 5,645,900 |
| Intangibles | 1,500,800 | 1,506,500 | 1,512,200 | 1,517,800 | 1,523,500 |
| Other Non-Current Assets | 5,924,700 | 5,889,300 | 5,697,200 | 5,627,000 | 5,104,300 |
| TOTAL | $14,879,600 | $14,754,100 | $14,442,000 | $14,292,700 | $13,608,800 |
| Total Assets | $27,423,300 | $26,484,400 | $25,643,000 | $24,862,300 | $24,036,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 429,500 | 489,300 | 461,700 | 420,300 | 442,300 |
| Accrued Expenses | 3,179,000 | 2,984,200 | 2,971,200 | 3,613,500 | 3,270,700 |
| Other current liabilities | 329,400 | 407,100 | 428,300 | 441,500 | 425,400 |
| TOTAL | $3,937,900 | $3,880,600 | $3,861,200 | $4,475,300 | $4,138,400 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,237,500 | 3,241,900 | 3,116,000 | 3,068,200 | 2,722,900 |
| TOTAL | $3,237,500 | $3,241,900 | $3,116,000 | $3,068,200 | $2,722,900 |
| Total Liabilities | $7,175,400 | $7,122,500 | $6,977,200 | $7,543,500 | $6,861,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 253,461 | 253,805 | 254,034 | 253,719 | 256,391 |
| Common Shares | 2,500 | 2,500 | 2,500 | 2,500 | 2,600 |
| Retained earnings | 15,691,200 | 14,591,400 | 13,560,000 | 12,368,900 | 11,286,000 |
| Other shareholders' equity | 48,500 | 24,800 | -15,900 | -64,500 | -101,100 |
| TOTAL | $20,247,900 | $19,361,900 | $18,665,800 | $17,318,800 | $17,175,400 |
| Total Liabilities And Equity | $27,423,300 | $26,484,400 | $25,643,000 | $24,862,300 | $24,036,700 |